Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections

Launched by CHINA MEDICAL UNIVERSITY HOSPITAL · Sep 23, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new device called the "AI Supporter," which is an intelligent robot designed to help manage urinary issues for patients who are bedridden. The robot uses advanced technology to identify and clean areas that may be affected by incontinence, which can lead to urinary tract infections and skin problems. The main goal of this study is to see if using the AI Supporter can reduce the number of urinary tract infections and skin issues in female patients who have been unable to move around for at least three months.

To participate in this trial, women over the age of 20 who have been bedridden and experience urinary or bowel incontinence may be eligible. Participants will use the AI Supporter for a two-week period, and their urine will be tested regularly to monitor any changes. It’s important to note that those with severe skin conditions unrelated to incontinence or current infections will not be able to join the study. This research aims not only to improve patient care but also to lessen the burden on caregivers, making it a significant step forward in managing incontinence.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Participants must have been bedridden for at least 3 months and have urinary and/or fecal incontinence.
• • Female participants aged over 20 years old.
• • Participants must be capable of wearing the AI-supporter device during the study period.
• Exclusion Criteria:
• • Participants with severe skin conditions unrelated to incontinence.
• • Participants with current urinary tract infections or incontinence-associated dermatitis at the time of enrollment.
• • Participants who are unable to provide informed consent or have a legal representative to do so.